UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:	April 29, 2020 10:30 A.M.

Form:	S-3
CIK: 0001557746 Company Name: Aclaris Therapeutics, Inc. File Number: 333-237163